EWTX - Edgewise Therapeutics Non-GAAP EPS of -$0.34 August, 10 2023 10:11 AM Edgewise Therapeutics Inc. 2023-08-10 10:11:44 ET Edgewise Therapeutics press release ( NASDAQ: EWTX ): Q2 Non-GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities were approximately $310 million as of June 30, 2023. For further details see: Edgewise Therapeutics Non-GAAP EPS of -$0.34